Chicago - 6:00 PM - 7:00 PM
The Center for Genetic Medicine of Northwestern University Feinberg School of Medicine welcomes you to attend the Silverstein Lecture Series on October 10 (Evanston) and October 11 (Chicago), featuring W. Ian Lipkin, MD, John Snow Professor of Epidemiology and Professor of Neurology and Pathology and Director, Center for Infection and Immunity, Mailman School of Public Health, Columbia University.
W. Ian Lipkin, MD, is internationally recognized as an authority on the use of molecular methods for pathogen discovery. Dr. Lipkin has over 30 years of experience in diagnostics, microbial discovery and outbreak response, has mentored and trained more than 30 students and post-doctoral fellows and leads a team of over 65 investigators, post-doctoral fellows and research and support staff in New York City and another 150 across the world. In the 1980s, Dr. Lipkin identified AIDS-associated immunological abnormalities and inflammatory neuropathy, which he showed could be treated with plasmapheresis, and demonstrated that early life exposure to viral infections affects neurotransmitter function. He was the first to use purely molecular methods to identify an infectious agent, developed MassTag PCR and GreeneChip technology and pioneered the use of high throughput sequencing in pathogen discovery. He and his team implicated West Nile virus as the cause of the encephalitis epidemic in New York in 1999 and have discovered or characterized more than 500 infectious agents including Borna disease virus, West Nile virus, LuJo virus and human rhinovirus C. Dr. Lipkin assisted the WHO and the Peoples Republic of China during the 2003 SARS outbreak and currently advises the Kingdom of Saudi Arabia in addressing the challenge of MERS. He also directs large programs focused on autism and chronic fatigue syndrome wherein gene-environment interactions such as infection and intoxication are postulated to cause disease.
The Silverstein Lecture Series was established by the Herman M. and Bea L. Silverstein Medical Research Fund for Genetic Medicine to bring advances in genetics research and medicine to the general public. The series features a renowned expert who discusses his or her research in a community forum. The events are always free and open to the public.